# TESARO, Inc.: Form D filings

TESARO, Inc., a pharmaceuticals company in Waltham, MA, filed 4 Form D notices with the SEC between 2010 and 2016. The latest, on April 18, 2016, reports $50 million sold of a $50 million offering to 1 investor.

Find out what TESARO, Inc. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.

- [Watch for new raises](https://specstream.ai/workspace/ask?q=Tell%20me%20when%20TESARO%2C%20Inc.%20files%20a%20new%20Form%20D%20or%20reports%20more%20money%20sold%2C%20with%20the%20filing&src=data-formd&kind=alert&entity=TESARO%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ftesaro-inc-1491576)
- [Get founders and investors](https://specstream.ai/workspace/ask?q=For%20TESARO%2C%20Inc.%2C%20find%20what%20the%20company%20does%2C%20its%20website%2C%20the%20founders%20and%20executives%20with%20their%20LinkedIn%20and%20work%20email%2C%20its%20investors%20and%20every%20funding%20round%20with%20the%20amounts%2C%20its%20headcount%20and%20any%20reported%20valuation&src=data-formd&kind=record&entity=TESARO%2C%20Inc.&page=%2Fdata%2Fform-d%2Fcompany%2Ftesaro-inc-1491576)

## The full lists

This record is a row of these lists. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email.

- [Form D filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts): 1,533 rows, by operating companies, filed since November 1, 2024, $76.65, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/state/massachusetts
- [Form D filings in Pharmaceuticals](https://specstream.ai/data/form-d/industry/pharmaceuticals): 346 rows, by operating companies, filed since November 1, 2024, $17.30, or the new rows each week for $19 a month. Buy: https://specstream.ai/data/form-d/industry/pharmaceuticals

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

## Company details from the filing

- Address: 1000 WINTER STREET, SUITE 3300, Waltham, MA, 02451
- Phone: (339) 970-0900
- Industry: Pharmaceuticals
- Entity type: Corporation
- Incorporated in: Delaware
- Revenue range: $1 - $1,000,000
- Exemptions claimed: Rule 506(b)
- SEC identifier (CIK): 1491576

## Form D filings

| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Apr 18, 2016 | New notice | $49,999,960 | $49,999,960 | $0 | 1 | Apr 5, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1491576/000113411516000001/0001134115-16-000001-index.htm) |
| Mar 10, 2016 | New notice | $154,999,915 | $154,999,915 | $0 | 7 | Feb 24, 2016 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1491576/000110465916104154/0001104659-16-104154-index.htm) |
| Jun 21, 2011 | New notice | $101,000,000 | $40,000,000 | $61,000,000 | 17 | Jun 6, 2011 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1491576/000114036111033696/0001140361-11-033696-index.htm) |
| May 20, 2010 | New notice | $20,000,000 | $10,000,000 | $10,000,000 | 5 | May 10, 2010 | [sec.gov](https://www.sec.gov/Archives/edgar/data/1491576/000149157610000001/0001491576-10-000001-index.htm) |

## Executive officers and directors named in the filing

| Name | Role | Note in the filing |
| --- | --- | --- |
| Grant C. Bogle | Executive Officer |  |
| Timothy R. Pearson | Executive Officer |  |
| Leon O. Moulder, Jr. | Executive Officer, Director |  |
| Mary Lynne O. Hedley | Executive Officer, Director |  |
| Jeffrey H. Hanke | Executive Officer |  |
| Kavita C. Patel | Director |  |
| Lawrence M. Alleva | Director |  |
| Earl M. Collier, Jr. | Director |  |
| Martin H. Huber | Executive Officer |  |
| Joseph L. Farmer | Executive Officer |  |
| James O. Armitage | Director |  |
| Garry A. Nicholson | Director |  |
| David M. Mott | Director |  |
| Beth L. Seidenberg | Director |  |
| Arnold L. Oronsky | Director |  |

## Other pharmaceuticals companies in Massachusetts that filed recently

- [BridgeHealth Pharmaceuticals, Inc.](https://specstream.ai/data/form-d/company/bridgehealth-pharmaceuticals-inc-2162724) $3.5 million · Nov 5, 2026
- [Land Therapeutics Inc.](https://specstream.ai/data/form-d/company/land-therapeutics-inc-2051104) $17.5 million · Oct 21, 2026
- [Crosslink Therapeutics Inc.](https://specstream.ai/data/form-d/company/crosslink-therapeutics-inc-2067583) $5.5 million · Oct 20, 2026
- [Sentonix, Inc.](https://specstream.ai/data/form-d/company/sentonix-inc-2039609) $12.7 million · Aug 20, 2026

[Every Form D from the week of Apr 18, 2016](https://specstream.ai/data/form-d/week/2016-04-18) · [All recent filings in Massachusetts](https://specstream.ai/data/form-d/state/massachusetts) · [All recent Pharmaceuticals filings](https://specstream.ai/data/form-d/industry/pharmaceuticals)

Read from SEC EDGAR. Amount sold is what TESARO, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under [CC BY 4.0](https://creativecommons.org/licenses/by/4.0/).